Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)

CUSIP: 03237H101

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
110,465,093
Total 13F shares
23,420,880
Share change
+23,419,117
Total reported value
$299,935,403
Put/Call ratio
9%
Price per share
$12.85
Number of holders
72
Value change
+$299,912,422
Number of buys
71

Security key

03237H101

Report period

Q1 2022

Institutions

72

Top holders

10

Top shareholders of AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
DRAGSA 96 LLC
3/4/5
10%+ Owner
class O/S missing
2,300,000
$37,554,630 11 Jan 2022

Institutional Holders of Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) as of Q1 2022

As of 31 Mar 2022, Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,420,880 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, Bain Capital Life Sciences Investors, LLC, BOXER CAPITAL, LLC, PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, VANGUARD GROUP INC, Verition Fund Management LLC, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, 683 Capital Management, LLC, and Alpha Wave Global, LP. This page lists 72 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2022 vs Q4 2025 Across Filers

Q4 2025 holders
180
Q1 2022 holders
72
Holder diff
-108
Investor Q4 2025 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .